Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go

被引：47
|
作者：
Lv, Meng [1 ]
Huang, Xiao-Jun [1 ]
机构：
[1] Peking Univ, Inst Hematol, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100044, Peoples R China
来源：
JOURNAL OF HEMATOLOGY & ONCOLOGY | 2012年 / 5卷
基金：
中国国家自然科学基金;
关键词：
China; Allo-HSCT; Haploidentical; Relapse; GVHD; Elderly patients; ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; DONOR LYMPHOCYTE INFUSION; RISK ACUTE-LEUKEMIA; ACUTE GVHD; ANTITHYMOCYTE GLOBULIN; MYCOPHENOLATE-MOFETIL; CLINICAL-OUTCOMES; T-CELLS; BLOOD;
D O I：
10.1186/1756-8722-5-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective and sometimes the only curative therapy for patients with certain hematological diseases. Allo-HSCT has been practiced in China for approximately 30 years, and great improvements have been made within the past decade, particularly in fields such as the haploidentical HSCT system, strategies to overcome relapse and GVHD, and modified HSCT for elderly patients. This review will describe the current situation and provide a prospective of these unique aspects of Allo-HSCT in China.
引用
收藏
页数：8
相关论文
共 50 条
  • [31] TAKEOVERS - WHERE ARE WE - WHERE DO WE GO
    SUBAK, JT
    BUSINESS LAWYER, 1986, 41 (04): : 1255 - 1264
  • [32] The Holocaust -: Where we are, where we need to go
    Jäckel, E
    HOLOCAUST AND HISTORY: THE KNOWN, THE UNKNOWN, THE DISPUTED, AND THE REEXAMINED, 1998, : 23 - 29
  • [33] Anticoagulation: where we are and where we need to go
    Barnes, Geoffrey D.
    Froehlich, James B.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) : 220 - 223
  • [34] LOUISIANA - WHERE WE ARE AND WHERE WE HOPE TO GO
    DURBIN, GJ
    SUGAR JOURNAL, 1978, 40 (10): : 8 - 8
  • [35] Synucleinopathies: Where we are and where we need to go
    Bras, Ines Caldeira
    Dominguez-Meijide, Antonio
    Gerhardt, Ellen
    Koss, David
    Lazaro, Diana F.
    Santos, Patricia, I
    Vasili, Eftychia
    Xylaki, Mary
    Outeiro, Tiago Fleming
    JOURNAL OF NEUROCHEMISTRY, 2020, 153 (04) : 433 - 454
  • [36] Organoids, Where We Stand and Where We Go
    Don, Flaminia Kaluthantrige
    Huch, Meritxell
    TRENDS IN MOLECULAR MEDICINE, 2021, 27 (05) : 416 - 418
  • [37] GRAVITATIONAL WAVES: WHERE WE ARE, WHERE WE GO
    Ricci, Fulvio
    7TH ROMA INTERNATIONAL CONFERENCE ON ASTROPARTICLE PHYSICS (RICAP18), 2019, 209
  • [38] Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
    Banz-Jansen, Constanze
    Helweg, Laureen P.
    Kaltschmidt, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [39] Anticoagulation: where we are and where we need to go
    Geoffrey D. Barnes
    James B. Froehlich
    Journal of Thrombosis and Thrombolysis, 2009, 28
  • [40] Apoptosis and cancer: where we are and where to go ...
    Zhivotovsky, B
    Orrenius, S
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (02) : 93 - 95
12345